Rare Disease – Patient Support Matters: The Unique Challenges of Being Rare
- Unique Pharma Science
- Nov 26, 2024
- 2 min read
Updated: Mar 11
Navigating the world of rare diseases presents unique and often daunting challenges. At Unique Pharma Science our team of seasoned experts has been deeply involved in every aspect of rare disease management—from clinical trial design and patient safety monitoring to the approval of life-saving treatments.
We understand the obstacles sponsors and marketing authorization holders face in providing access to critical therapies. Our experts have worked tirelessly to ensure that patients with rare diseases receive the treatments they need. This includes opening new clinical trial sites, launching early access programs, establishing patient support initiatives, developing disease and drug registries, creating additional risk mitigation strategies, and coordinating with regulatory authorities to facilitate patient access to life-changing treatments.
One of the most compelling examples of our team’s dedication to patient support involves a clinical trial in the rare disease setting. During this study, our team discovered a young child who was living with a rare disease. Unfortunately, there were no open clinical trial sites in the country at the time, and no options for enrolling the patient.
Our team immediately sprang into action, exploring all available avenues to get the child the treatment they urgently needed. After some initial efforts, we realized that the nearest clinical trial site was located in a neighbouring country. However, logistical and regulatory hurdles prevented us from transferring the patient to this site.
Undeterred, our team continued to investigate other solutions and identified the only viable option: an early access program, which would allow the patient to receive treatment before the drug became commercially available. This solution required intensive coordination with multiple teams, regulatory agencies, and the Ministry of Health to ensure the patient could access the treatment.
Thanks to the tireless efforts of our team, the child was successfully enrolled in the early access program and is now making progress every day.
At Unique Pharma Science we remain committed to overcoming the challenges of rare disease treatment and ensuring that every patient, no matter how rare, gets the support they deserve.

Comments